John Leaman - Dec 31, 2022 Form 4 Insider Report for IMPEL PHARMACEUTICALS INC (IMPL)

Role: Chief Fin. & Business Officer
Signature: /s/ John Leaman, M.D.
Stock symbol: IMPL
Transactions as of: Dec 31, 2022
Transactions value $: -$13,601
Form type: 4
Date filed: 1/4/2023, 05:46 PM
Previous filing: Jan 28, 2022
Next filing: Feb 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMPL	Common Stock	Options Exercise	$0	+10.6K		$0.00	10.6K	Dec 31, 2022	Direct
transaction	IMPL	Common Stock	Tax liability	-$13.6K	-3.63K	-34.31%	$3.75	6.94K	Dec 31, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMPL	Restricted Stock Units (RSUs)	Options Exercise	$0	-10.6K	-100%	$0.00^*	0	Dec 31, 2022	Common Stock	10.6K		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units ("RSUs") and does not represent a sale by the reporting person.
F2	Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement.
F3	The RSUs vest as to 100% of the total shares on December 31, 2022, subject to the Reporting Person's continuation of employment on such vesting date.
F4	RSUs do not expire; they either vest or are canceled prior to the vesting date.